These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 23070908)
1. Cervical cancer with polymorphism in MTHFR C677T gene: a systematic review and meta-analysis. Xu XJ; Zou LW; Wang DB Mol Biol Rep; 2013 Jan; 40(1):255-62. PubMed ID: 23070908 [TBL] [Abstract][Full Text] [Related]
2. The association between MTHFR polymorphisms and cervical cancer risk: a system review and meta analysis. Yi K; Yang L; Lan Z; Xi M Arch Gynecol Obstet; 2016 Sep; 294(3):579-88. PubMed ID: 26879954 [TBL] [Abstract][Full Text] [Related]
3. Association between Methylenetetrahydrofolate reductase C677T polymorphism and susceptibility to cervical cancer: a meta-analysis. Yu L; Chang K; Han J; Deng S; Chen M PLoS One; 2013; 8(2):e55835. PubMed ID: 23431363 [TBL] [Abstract][Full Text] [Related]
4. Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and susceptibility for cervical lesions: a meta-analysis. Long S; Yang X; Liu X; Yang P PLoS One; 2012; 7(12):e52381. PubMed ID: 23285018 [TBL] [Abstract][Full Text] [Related]
5. Association between MTHFR C677T, MTHFR A1298C and MS A2756G polymorphisms and risk of cervical intraepithelial neoplasia II/III and cervical cancer: a meta-analysis. Zhu J; Wu L; Kohlmeier M; Ye F; Cai W Mol Med Rep; 2013 Sep; 8(3):919-27. PubMed ID: 23864153 [TBL] [Abstract][Full Text] [Related]
6. MTHFR C677T polymorphism was an ethnicity-dependent risk factor for cervical cancer development: evidence based on a meta-analysis. Wu CY; Yang M; Lin M; Li LP; Wen XZ Arch Gynecol Obstet; 2013 Sep; 288(3):595-605. PubMed ID: 23463325 [TBL] [Abstract][Full Text] [Related]
7. MTHFR C677T and A1298C polymorphisms and cervical carcinoma susceptibility: meta-analyses based on 4,421 individuals. Zhuo WL; Zhang L; Ling JJ; Zhu Y; Chen ZT Mol Biol Rep; 2012 Sep; 39(9):8723-32. PubMed ID: 22711309 [TBL] [Abstract][Full Text] [Related]
8. Quantitative assessment of the associations between MTHFR C677T and A1298C polymorphisms and risk of fractures: a meta-analysis. Bai R; Liu W; Zhao A; Zhao Z; Jiang D Mol Biol Rep; 2013 Mar; 40(3):2419-30. PubMed ID: 23229495 [TBL] [Abstract][Full Text] [Related]
9. The association between MTHFR C677T polymorphism and ovarian cancer risk: a meta-analysis of 18,628 individuals. Ma C; Liu Y; Zhang W; Liu P Mol Biol Rep; 2013 Mar; 40(3):2061-8. PubMed ID: 23329275 [TBL] [Abstract][Full Text] [Related]
10. Significant association between MTHFR C677T polymorphism and hepatocellular carcinoma risk: a meta-analysis. Sun H; Han B; Zhai H; Cheng X; Ma K Tumour Biol; 2014 Jan; 35(1):189-93. PubMed ID: 24132589 [TBL] [Abstract][Full Text] [Related]
11. The polymorphism of methylenetetrahydrofolate reductase C677T but not A1298C contributes to gastric cancer. Lv L; Wang P; Sun B; Chen G Tumour Biol; 2014 Jan; 35(1):227-37. PubMed ID: 23897558 [TBL] [Abstract][Full Text] [Related]
12. Quantitative assessment of the association between MTHFR C677T polymorphism and hemorrhagic stroke risk. Zhao X; Jiang H Mol Biol Rep; 2013 Jan; 40(1):573-8. PubMed ID: 23184002 [TBL] [Abstract][Full Text] [Related]
13. The association between MTHFR 677C>T polymorphism and cervical cancer: evidence from a meta-analysis. Mei Q; Zhou D; Gao J; Shen S; Wu J; Guo L; Liang Z BMC Cancer; 2012 Oct; 12():467. PubMed ID: 23057736 [TBL] [Abstract][Full Text] [Related]
14. MTHFR C677T polymorphism contributes to colorectal cancer susceptibility: evidence from 61 case-control studies. Sheng X; Zhang Y; Zhao E; Lu S; Zheng X; Ge H; Lu W Mol Biol Rep; 2012 Oct; 39(10):9669-79. PubMed ID: 22729883 [TBL] [Abstract][Full Text] [Related]
15. Lack of association between methylenetetrahydrofolate reductase C677T polymorphism, HPV infection and cervical intraepithelial neoplasia in Brazilian women. Silva NNT; Sabino AP; Tafuri A; Lima AA BMC Med Genet; 2019 Jun; 20(1):100. PubMed ID: 31170928 [TBL] [Abstract][Full Text] [Related]
16. Association of the maternal MTHFR C677T polymorphism with susceptibility to neural tube defects in offsprings: evidence from 25 case-control studies. Yan L; Zhao L; Long Y; Zou P; Ji G; Gu A; Zhao P PLoS One; 2012; 7(10):e41689. PubMed ID: 23056169 [TBL] [Abstract][Full Text] [Related]
17. MTHFR C677T polymorphism and osteoporotic fracture in postmenopausal women: a meta-analysis. Guan JZ; Wu M; Xiao YZ; Zhou JS; Wang ZD Genet Mol Res; 2014 Sep; 13(3):7356-64. PubMed ID: 25222234 [TBL] [Abstract][Full Text] [Related]
18. Methylenetetrahydrofolate reductase C677T polymorphism and susceptibility to cervical cancer and cervical intraepithelial neoplasia: a meta-analysis. Luo YL; Ye P; Zhang QH; Hu TT; Luo MH; Li MQ; Chen Q PLoS One; 2012; 7(9):e46272. PubMed ID: 23029458 [TBL] [Abstract][Full Text] [Related]
19. Methylenetetrahydrofolate reductase C677T polymorphism and cervical cancer risk: a meta-analysis. Guo LN Asian Pac J Cancer Prev; 2012; 13(5):2193-7. PubMed ID: 22901193 [TBL] [Abstract][Full Text] [Related]
20. Association between MTHFR C677T polymorphism and thyroid cancer risk: a meta-analysis. Yan Y; Han F; Fu H; Xia W; Qin X Tumour Biol; 2014 Aug; 35(8):7707-12. PubMed ID: 24805831 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]